What does DR. DE SPIEGELEIRE - DR. STEEN do?

DR. DE SPIEGELEIRE - DR. STEEN is a specialist medical practice in Staden. Private Limited, started on 1 February 2016, 2 establishments.

What is the address of DR. DE SPIEGELEIRE - DR. STEEN?

The registered office of DR. DE SPIEGELEIRE - DR. STEEN is located at Walstraat(STA) 2 box B, 8840 Staden.

Is DR. DE SPIEGELEIRE - DR. STEEN still active?

Yes. According to the CBE (15 September 2026) DR. DE SPIEGELEIRE - DR. STEEN is active, legal situation “Normale toestand”, started on 1 February 2016.

Is DR. DE SPIEGELEIRE - DR. STEEN registered on Peppol?

Yes, DR. DE SPIEGELEIRE - DR. STEEN is registered on the Peppol network with ID 0208:0647681470.

What is the enterprise number of DR. DE SPIEGELEIRE - DR. STEEN?

The enterprise number of DR. DE SPIEGELEIRE - DR. STEEN is BE0647681470.

When was DR. DE SPIEGELEIRE - DR. STEEN founded?

DR. DE SPIEGELEIRE - DR. STEEN was founded on 1 February 2016.

Who are the directors of DR. DE SPIEGELEIRE - DR. STEEN?

According to the 2025 annual accounts, the directors of DR. DE SPIEGELEIRE - DR. STEEN are: Evi Steen, Jonas De Spiegeleire.

Is DR. DE SPIEGELEIRE - DR. STEEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 February 2016; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. DE SPIEGELEIRE - DR. STEEN make in 2025?

DR. DE SPIEGELEIRE - DR. STEEN posted a profit after taxes of € 585,948 in financial year 2025.

What is the revenue of DR. DE SPIEGELEIRE - DR. STEEN?

As a small company, DR. DE SPIEGELEIRE - DR. STEEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 757,274.

DR. DE SPIEGELEIRE - DR. STEEN (Private Limited) - Staden

Dossier DR. DE SPIEGELEIRE - DR. STEEN, printed on 15 September 2026 from databakkes.be/en/0647681470/dr-de-spiegeleire-dr-steen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. DE SPIEGELEIRE - DR. STEEN from Staden, company number BE0647681470, closed financial year 2025 with a result of € 585,948 after tax. For that financial year DR. DE SPIEGELEIRE - DR. STEEN recorded a gross margin of € 757,274 and equity of € 608,562. Compared with financial year 2024, the result moved from € 377,198 to € 585,948. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.

What it is worth Growing

€ 608,562

▲ 52% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 585,948

▲ 55% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 210,264

▲ 228% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 377,000 paid out

64 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 98,007

▼ 9% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,990

▼ 46% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 32,742

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 382,141 Gross margin 2022: € 382,141 First fiscal year in the series	€ 432,225 Gross margin 2023: € 432,225 ▲ 13% vs 2022 (€ 382,141) Favourable step	€ 545,115 Gross margin 2024: € 545,115 ▲ 26% vs 2023 (€ 432,225) Favourable step	€ 757,274 Gross margin 2025: € 757,274 ▲ 39% vs 2024 (€ 545,115) Favourable step	▲ 39%
Profit after taxes	€ 275,236 Profit after taxes 2022: € 275,236 First fiscal year in the series	€ 313,127 Profit after taxes 2023: € 313,127 ▲ 14% vs 2022 (€ 275,236) Favourable step	€ 377,198 Profit after taxes 2024: € 377,198 ▲ 20% vs 2023 (€ 313,127) Favourable step	€ 585,948 Profit after taxes 2025: € 585,948 ▲ 55% vs 2024 (€ 377,198) Favourable step	▲ 55%
Equity	€ 355,290 Equity 2022: € 355,290 First fiscal year in the series	€ 418,417 Equity 2023: € 418,417 ▲ 18% vs 2022 (€ 355,290) Favourable step	€ 399,615 Equity 2024: € 399,615 ▼ 4% vs 2023 (€ 418,417) Unfavourable step	€ 608,562 Equity 2025: € 608,562 ▲ 52% vs 2024 (€ 399,615) Favourable step	▲ 52%
Total debts	€ 47,969 Total debts 2022: € 47,969 First fiscal year in the series	€ 272,353 Total debts 2023: € 272,353 ▲ € 224,385 vs 2022 (€ 47,969) Unfavourable step	€ 83,877 Total debts 2024: € 83,877 ▼ 69% vs 2023 (€ 272,353) Favourable step	€ 93,194 Total debts 2025: € 93,194 ▲ 11% vs 2024 (€ 83,877) Unfavourable step	▲ 11%
Cash	€ 77,643 Cash 2022: € 77,643 First fiscal year in the series	€ 234,641 Cash 2023: € 234,641 ▲ 202% vs 2022 (€ 77,643) Favourable step	€ 64,180 Cash 2024: € 64,180 ▼ 73% vs 2023 (€ 234,641) Unfavourable step	€ 210,264 Cash 2025: € 210,264 ▲ 228% vs 2024 (€ 64,180) Favourable step	▲ 228%
Retained profit	€ 336,690 Retained profit 2022: € 336,690 First fiscal year in the series	€ 399,817 Retained profit 2023: € 399,817 ▲ 19% vs 2022 (€ 336,690) Favourable step	€ 381,015 Retained profit 2024: € 381,015 ▼ 5% vs 2023 (€ 399,817) Unfavourable step	€ 589,962 Retained profit 2025: € 589,962 ▲ 55% vs 2024 (€ 381,015) Favourable step	▲ 55%
Dividend	€ 250,000 Dividend 2022: € 250,000 First fiscal year in the series	€ 250,000 Dividend 2023: € 250,000 Unchanged (€ 250,000) Unchanged	€ 396,000 Dividend 2024: € 396,000 ▲ 58% vs 2023 (€ 250,000) Unchanged	€ 377,000 Dividend 2025: € 377,000 ▼ 5% vs 2024 (€ 396,000) Unchanged	▼ 5%
Balance sheet total	€ 403,258 Balance sheet total 2022: € 403,258 First fiscal year in the series	€ 690,770 Balance sheet total 2023: € 690,770 ▲ 71% vs 2022 (€ 403,258) Unchanged	€ 483,491 Balance sheet total 2024: € 483,491 ▼ 30% vs 2023 (€ 690,770) Unchanged	€ 701,756 Balance sheet total 2025: € 701,756 ▲ 45% vs 2024 (€ 483,491) Unchanged	▲ 45%

Key figures of DR. DE SPIEGELEIRE - DR. STEEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. DE SPIEGELEIRE - DR. STEEN?

What happened at DR. DE SPIEGELEIRE - DR. STEEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 9, 2026 New annual accounts for financial year 2025: profit of € 585,948 (▲ 55% vs 2024). Source: NBB ↗
Feb 1, 2016 New establishment in Brugge. KBO
Feb 1, 2016 New establishment in Staden. KBO
Feb 1, 2016 Start of the company according to the CBE. KBO

In short

From € 275,236 profit in 2022 to € 585,948 profit in 2025.

Paid € 488,763 in corporate taxes since 2022.

Best year ever: 2025, with € 585,948 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. DE SPIEGELEIRE - DR. STEEN? We notify you, reason included.

Follow DR. DE SPIEGELEIRE - DR. STEEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Evi Steen

Jonas De Spiegeleire

DR. DE SPIEGELEIRE - DR. STEEN

Huisartsenpraktijk De Biekorf 33.3%

Behind DR. DE SPIEGELEIRE - DR. STEEN are Evi Steen and Jonas De Spiegeleire. It owns 33.3% of Huisartsenpraktijk De Biekorf itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Evi Steen

Director

Jonas De Spiegeleire

Director

Also active at: HUISARTSENPRAKTIJK DE BIEKORF

Establishments

Establishment units

Physical locations of this company

Registered office

Walstraat(STA) 2 box B

8840 Staden

2.250.591.327

Ruddershove 10

8000 Brugge

Active since 1 February 2016

2.250.591.426

Diksmuidestraat(STA) 12